title: Measles-mumps-rubella and hepatitis B vaccination uptake in adolescents: a survey in metropolitan Melbourne.
abstract: OBJECTIVE
  To measure the uptake of preadolescent measles-mumps-rubella (MMR) and adolescent hepatitis B vaccinations and assess the influence of certain demographic factors on the uptake of these vaccines.
  
  
  METHODS
  Prevalence surveys of uptake rates of preadolescent (school Year 6; age 10-11 years) MMR and adolescent (school Year 9; age 13-14 years) hepatitis B vaccination.
  
  
  METHODS
  City of Darebin, an inner northern metropolitan region of Melbourne, 1996.
  
  
  METHODS
  1160 Year 6 school students (580 boys) and 1102 Year 9 school students (548 boys).
  
  
  METHODS
  School-based vaccination program administered by Darebin Council.
  
  
  RESULTS
  83% of Year 6 students were vaccinated with the MMR vaccine (84.1% of girls and 81.9% of boys). 71.6% of Year 9 students completed the full course of hepatitis B vaccination (68.9% of boys and 74.2% of girls). There was a higher uptake of MMR in non-government primary schools, but no other demographic factors (sex, economic status, non-English-speaking background, parental education, school class size) were associated.
  
  
  CONCLUSIONS
  These uptake rates do not meet National Health and Medical Research Council (NHMRC) recommendations. Further study is required to determine and quantify the factors that affect vaccination uptake in adolescence. Programs may then be developed to improve vaccination uptake.
authors.affiliation: Royal Children's Hospital, Melbourne, VIC. skinnerr@cryptic.rch.unimelb.edu.au
authors.forename: S R
authors.initials: SR
authors.lastname: Skinner
authors.forename: T
authors.initials: T
authors.lastname: Nolan
authors.forename: G
authors.initials: G
authors.lastname: Bowes
mesh_terms: D000293:Adolescent; D016497:Adolescent Health Services / Q000706:statistics & numerical data*; D002648:Child; D006297:Health Services Accessibility; D017325:Hepatitis B Vaccines / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D008458:Measles Vaccine / Q000008:administration & dosage*; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care / Q000706:statistics & numerical data*; D015995:Prevalence; D012411:Rubella Vaccine / Q000008:administration & dosage*; D012959:Socioeconomic Factors; D014611:Vaccination / Q000706:statistics & numerical data*; D017778:Vaccines, Combined / Q000008:administration & dosage; D014739:Victoria / Q000453:epidemiology
chemical_list: D017325:Hepatitis B Vaccines; D008458:Measles Vaccine; D022542:Measles-Mumps-Rubella Vaccine; D009108:Mumps Vaccine; D012411:Rubella Vaccine; D017778:Vaccines, Combined